Can KalVista Pharmaceuticals Stock Fly Higher?
The biotech industry's a wonky place where the outlook for a company's future can, and often does, change overnight. Successful clinical trial results for a potential drug from KalVista Pharmaceuticals (NASDAQ: KALV) caused its stock price to rocket 114% higher on Tuesday. Investors are right to wonder if there's still fuel in the tank to push it even higher.
Before making any predictions about KalVista Pharmaceuticals' future, we should take a quick look at what drove the stock higher.
Image source: Getty Images.
Source Fool.com
